There is a high demand for safe and long-lasting medications to treat bone loss for the millions of people with osteoporosis. Discovering new targets for drug development is therefore a key step towards better therapies. In a recent study, scientists at Leipzig University in Germany demonstrated that the G protein receptor called GPR133 plays a […]
There is a high demand for safe and long-lasting medications to treat bone loss for the millions of people with osteoporosis.
Discovering new targets for drug development is therefore a key step towards better therapies.
In a recent study, scientists... [1794 chars]